Radiolabelled compounds

The present invention provides novel radiolabeled monoacylglycerol lipase (MAGL) inhibitors that are useful in medical imaging such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and/or radioautography. 本发明提供了新的放射性标记的单酰基甘油脂肪酶(MAGL)抑制剂，所述抑制剂可用于医学成像诸如正电子发射断层...

Full description

Saved in:
Bibliographic Details
Main Authors MURI DIETER, O 'HARA FIONN, CARROLL CARSTEN, HE YINGFANG, RICHTER HANS, EDELMANN MARTIN, HOHENSPOORG, BENOU T, COLLIN LUDOVIC, MU LINJING, GOBBI LUCA, GRETHER UWE, RITTER MARTIN, HARTUNG THOMAS, HONER MICHAEL
Format Patent
LanguageChinese
English
Published 21.06.2022
Subjects
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides novel radiolabeled monoacylglycerol lipase (MAGL) inhibitors that are useful in medical imaging such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and/or radioautography. 本发明提供了新的放射性标记的单酰基甘油脂肪酶(MAGL)抑制剂，所述抑制剂可用于医学成像诸如正电子发射断层扫描(PET)、单光子发射计算机断层扫描(SPECT)和/或放射自显影。
Bibliography:Application Number: CN202080064238